Is NYC a biotech hub? Gut-brain start­up Kally­ope, equipped with $66M in new mon­ey, says yes

In a win for New York City’s hope­ful biotech scene, Co­lum­bia Uni­ver­si­ty spin­out Kally­ope has nailed down a $66 mil­lion fi­nanc­ing round with plans of grow­ing the start­up’s staff in NYC’s life sci­ence core.

The com­pa­ny got the Se­ries B cash from many of the same in­vestors that con­tributed to their A round, in­clud­ing Lux Cap­i­tal, The Col­umn Group, and Il­lu­mi­na Ven­tures, among oth­ers.

Kally­ope is led by CEO Nan­cy Thorn­ber­ry, a long­time Mer­ck vet­er­an who joined the com­pa­ny in 2015 when there was on­ly six peo­ple on staff. To­day, the com­pa­ny em­ploys 44 and plans to grow its staff to 60 by the end of this year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.